Status:
COMPLETED
Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
Lead Sponsor:
Ankara Training and Research Hospital
Conditions:
Stone, Kidney
Urolithiasis
Eligibility:
All Genders
18-80 years
Brief Summary
Retrograde intrarenal surgery (RIRC) is used as standard treatment for stones less than 2 cm. In some cases, the ureteral access sheath cannot be placed due to ureteral stricture. In this case, a doub...
Eligibility Criteria
Inclusion
- Patients with a DJ stent for passive dilatation and subsequent RIRC
Exclusion
- Urinary tract infection, patients with ureteral compression and a history of pelvic radiotherapy, urinary system tumor
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05340088
Start Date
September 1 2021
End Date
February 1 2022
Last Update
April 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Training and Research Hospital
Ankara, Altindag, Turkey (Türkiye), 06230